Skip to main content
. 2011 May 31;5(5):e1171. doi: 10.1371/journal.pntd.0001171

Figure 4. Ex vivo analysis of mRNA expression in different clinical manifestations of PKDL.

Figure 4

Ex vivo analysis of relative Treg markers and IL-10 mRNA levels in Nodular (N) (n = 12) and Macular/Papular (M/P) (n = 10) lesions in distinct forms of PKDL. ***P<0.001.